Different recommendations for empiric first-choice antibiotic treatment of uncomplicated urinary tract infections in Europe

References

• Nicolle L, Anderson PA, Conly J, Mainprize TC, Meuser J, Nickel JC, et al. Uncomplicated urinary tract infection in women: Current practice and the effect of antibiotic resistance on empiric treatment. Can Fam Physician 2006;52: 612–18.
   PubMed Web of Science ®Google Scholar
• Christiaens TC, De MM, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract 2002;52:729–34.
   PubMed Web of Science ®Google Scholar
• Ferry SA, Holm SE, Stenlund H, Lundholm R, Monsen TJ. The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Scand J Infect Dis 2004;36:296–301.
   PubMed Web of Science ®Google Scholar
• Nicolle LE. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am 2008;35:1–12.
   PubMed Web of Science ®Google Scholar
• Falagas ME, Kotsantis IK, Vouloumanou EK, Rafailidis PI. Antibiotics vs. placebo in the treatment of women with uncomplicated cystitis: A meta-analysis of randomized controlled trials. J Infect 2009;58:91–102.
   PubMed Web of Science ®Google Scholar
• Critically Important Antimicrobials for Human Medicine. 2nd Revision –2009. WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR). Geneva: World Health Organization, Department of Food Safety and Zoonoses;2009.
   Google Scholar
• Goossens H, Ferech M, Vander SR, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: S cross-national database study. Lancet 2005; 365:579–87.
   PubMed Web of Science ®Google Scholar
• Danmap 2009 [internet]. Use of antimicrobial agents and occurrence of antimicrobial resistance from food animals, fruits and humans in Denmark. [cited 1–6–2011.] Available from: www.danmap.org. 2009.
   Google Scholar
• Kahlmeter G. The ECO.SENS Project: A prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens – interim report. J Antimicrob Chemother 2000; 46(Suppl 1):15–22.
   Google Scholar
• ECDC/EMEA [internet]. Joint Technical Report.The bacterial challenge: Time to react. 2009 [cited 5–12–2012]. Available from: EMEA/576176/2009.www.ema.europa.eu/docs/en_GB/document_library/Report/2009/11/WC500008770. pdf.09.2009; vii.
   Google Scholar
• Le TP, Miller LG. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: A decision and cost analysis. Clin Infect Dis 2001;33:615–21.
   PubMed Web of Science ®Google Scholar
• Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52: e103–e120.
   PubMed Web of Science ®Google Scholar
• Raz R, Chazan B, Kennes Y, Colodner R, Rottensterich E, Dan M, et al. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis 2002;34:1165–9.
   PubMed Web of Science ®Google Scholar
• IRF, Institut for Rationel Farmakoterapi [internet]. Antibiotika til systemisk brug [Institute for Rational Pharmacotherapy, Antibiotics for systemic use].12–2–2009. [cited 1–5–2012]. Available from: http://www.irf.dk/dk/rekommandationsliste/infektionssygdomme/antibiotika_systemisk_brug/test_sulfonamider_og_trimethoprim_j01e.htm.
   Google Scholar
• Basislisten 2011 [internet]. Basislisten, lægens værktøj til rationel medicinordination [The basic list, the doctor's tool for rational drug prescribing]. [cited 3–2–2012]. Available from: https://www.sundhed.dk/content/cms/15/4915_2012-basislisten.pdf
   Google Scholar
• Helweg-Larsen J, Frimodt-Moller N, Nielsen H, Dahl Knudsen J, Holme P. Antibiotika (systemisk brug), baggrundsnotat, 2009 [Antibiotics (systemic use), background notes, 2009]. [internet]. [cited 12–9–2009]. Available from: http://www.irf.dk/dk/rekommandationsliste/baggrundsnotater/infektionssygdomme/antibiotika_systemisk_brug.htm#Uro–genitale_infektioner.
   Google Scholar
• Gahrn-Hansen B, Kolmos HJJ. Antibiotikapolitik og behandling af hyppigt forekommende infektioner i almen praksis [Policy of antibiotics and treatment of common infections in general practice]. Copenhagen: Institute for Rational Pharmacotherapy, Danish Medicines Agency; 2001. p. 7.
   Google Scholar
• André M, Ahlqvist-Rastad J, Beermann B. Nedre urinvägsinfektion (UVI) hos kvinnor – Behandlingsrekommendation [Lower urinary tract infection (UTI) in women – Treatment recommendation]. Läkemedelsverket 2007;2:8–15.
   Google Scholar
• Scottish Intercollegiate Guideline Network. Management of suspected bacterial urinary tract infection in adults: A national clinical guideline; 2012. p. 7–12.
   Google Scholar
• Skerk V, Andrasevic AT, Andrasevic S, Susic E, Dzepina AM, Madaric V, et al. [ISKRA guidelines on antimicrobial treatment and prophylaxis of urinary tract infections – Croatian national guidelines]. Lijec Vjesn 2009;131:105–18.
   PubMedGoogle Scholar
• Rabanaque G, Romera Á, Domingo C, Herrera C, Plana A, Sánchez J. Infecciones del tracto urinario [Urinary tract infections]. Manual de enfermedades infecciones en atención primaria [Handbook of infectious diseases in primary helth care]. Barcelona: 2010. p. 153–81.
   Google Scholar
• Wagenlehner FM, Schmiemann G, Hoyme U, Funfstuck R, Hummers-Pradier E, Kaase M, et al. Nationale S3-Leitlinie, unkomplizierte harnwegsinfektionen. Empfehlungen zu terapie und management unkomplizierter bakterieller ambulant erworbener harnwegsinfektionen bei erwachsenen patienten[S3 guideline for uncomplicated urinary tract infections – treatment guidelines compliance]. Med Monatsschr Pharm 2011;34:164–8.
   PubMedGoogle Scholar
• Gahrn-Hansen B, Søgaard P. Midler mod bakterielle infektionssygdomme [Agents for treatment of bacterial infectious diseases] In: Kampmann JP, Brøsen K, Simonsen U, editors. Basal og klinisk farmakologi [Basic and clinical phamacology]. 3rd ed. Copenhagen: FADL‘s forlag A/S; 2007. p. 601–21.
   Google Scholar
• Naber K, Schito G, Botto H, Palou J, Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): Implications for empiric therapy. Eur Urology 2008:54:1164–78.
   PubMed Web of Science ®Google Scholar
• Dalhoff A. Resistance surveillance studies: A multifaceted problem – the fluoroquinolone example. Infection 2012;40: 239–62.
   PubMed Web of Science ®Google Scholar
• Kerrn MB, Klemmensen T, Frimodt-Moller N, Espersen F. Susceptibility of Danish Escherichia coli strains isolated from urinary tract infections and bacteraemia, and distribution of sul genes conferring sulphonamide resistance. J Antimicrob Chemother 2002;50:513–16.
   PubMed Web of Science ®Google Scholar
• Llor C, Aspiroz C, Cano A, Barranco M. The use of amoxicillin and clavulanic acid and quinolones as first choice antibiotics in uncomplicated urinary tract infections in Spain should be reviewed. Aten Primaria 2012;44:443–4.
   PubMed Web of Science ®Google Scholar
• Cuevas O, Oteo J, Lazaro E, Aracil B, de AF, Garcia-Cobos S, et al. Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid. J Antimicrob Chemother 2011;66:664–9.
   PubMed Web of Science ®Google Scholar
• Campos J, Ferech M, Lazaro E, Abajo F, Oteo J, Stephens P, et al. Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother 2007;60:698–701.
   PubMed Web of Science ®Google Scholar
• Llor C, Cots JM. The sale of antibiotics without prescription in pharmacies in Catalonia, Spain. Clin Infect Dis 2009;48: 1345–9.
   PubMed Web of Science ®Google Scholar
• Morgan DJ, Okeke I, Laxminarayan R, Perencevich E, Weisenberg S. Non-prescription antimicrobial use worldwide: A systematic review. Lancet Infect Dis 2011;11: 692–701.
   PubMed Web of Science ®Google Scholar
• Grave K, Torren-Edo J, Mackay D. Comparison of the sales of veterinary antibacterial agents between 10 European countries. J Antimicrob Chemother 2010;65:2037–40.
   PubMed Web of Science ®Google Scholar